DONNA EUBANKS: Open Payments
NPI 1043641178 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$627 in 24 payments from 11 companies in 2025. Trend: 2023 $235 · 2024 $605 · 2025 $627
Food & beverage: $627
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $263 |
| Galderma Laboratories, L.P. | 1 | $95 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $77 |
| CSL Behring | 2 | $35 |
| GENZYME CORPORATION | 1 | $29 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| LEO Pharma Inc. | 1 | $21 |
| Amgen Inc. | 1 | $20 |
| Kedrion Biopharma, Inc. | 1 | $18 |
Products named: FASENRA, AIRSUPRA, NEMLUVIO, TEZSPIRE, CUVITRU, DUPIXENT, XOLAIR, TRELEGY ELLIPTA.
Industry payments across AZ — which companies pay providers there.
